Processa Pharmaceuticals Inc (PCSA)
2.26
+0.04
(+1.80%)
USD |
NASDAQ |
May 02, 16:00
2.26
0.00 (0.00%)
After-Hours: 20:00
Processa Pharmaceuticals Enterprise Value: 1.634M for May 1, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| May 01, 2024 | 1.634M |
| April 30, 2024 | 1.520M |
| April 29, 2024 | 1.291M |
| April 26, 2024 | 1.434M |
| April 25, 2024 | 2.234M |
| April 24, 2024 | -0.0795M |
| April 23, 2024 | -0.1366M |
| April 22, 2024 | -0.3365M |
| April 19, 2024 | -0.1937M |
| April 18, 2024 | -0.2508M |
| April 17, 2024 | 0.0348M |
| April 16, 2024 | -0.308M |
| April 15, 2024 | -0.3794M |
| April 12, 2024 | 0.0633M |
| April 11, 2024 | 0.3204M |
| April 10, 2024 | 0.5488M |
| April 09, 2024 | 3.605M |
| April 08, 2024 | 3.819M |
| April 05, 2024 | 3.262M |
| April 04, 2024 | 1.920M |
| April 03, 2024 | 2.034M |
| April 02, 2024 | 2.548M |
| April 01, 2024 | 2.005M |
| March 28, 2024 | 2.048M |
| March 27, 2024 | 1.777M |
| Date | Value |
|---|---|
| March 26, 2024 | 1.491M |
| March 25, 2024 | 1.720M |
| March 22, 2024 | 1.691M |
| March 21, 2024 | 1.491M |
| March 20, 2024 | -0.898M |
| March 19, 2024 | -0.8468M |
| March 18, 2024 | -0.7956M |
| March 15, 2024 | -0.9663M |
| March 14, 2024 | -0.898M |
| March 13, 2024 | -0.7956M |
| March 12, 2024 | -0.8297M |
| March 11, 2024 | -0.8126M |
| March 08, 2024 | -0.8297M |
| March 07, 2024 | -0.7614M |
| March 06, 2024 | -0.7443M |
| March 05, 2024 | -0.8126M |
| March 04, 2024 | -0.4199M |
| March 01, 2024 | -0.5053M |
| February 29, 2024 | -0.5053M |
| February 28, 2024 | -0.676M |
| February 27, 2024 | -0.7443M |
| February 26, 2024 | -1.086M |
| February 23, 2024 | -0.9493M |
| February 22, 2024 | -0.8468M |
| February 21, 2024 | -0.8297M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.661M
Minimum
Sep 28 2023
188.70M
Maximum
Mar 18 2021
41.26M
Average
31.06M
Median
Sep 12 2022
Enterprise Value Benchmarks
| Panbela Therapeutics Inc | 4.606M |
| Spectral AI Inc | 21.08M |
| Fate Therapeutics Inc | 90.71M |
| Checkpoint Therapeutics Inc | 44.68M |
| Palisade Bio Inc | -6.287M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -2.405M |
| Total Expenses (Quarterly) | 2.470M |
| EPS Diluted (Quarterly) | -1.68 |
| Earnings Yield | -392.9% |
| Normalized Earnings Yield | -6239.75 |